Publications by authors named "Kenji Onoue"

Background: The effects of myocarditis after mRNA COVID-19 vaccination (mCV) on myocardial tissue, and the association between cardiomyocyte injury and clinical presentation, are not fully understood.

Methods And Results: We retrospectively registered patients clinically diagnosed with myocarditis after the first or second mCV who underwent endomyocardial biopsy or autopsy from 42 participating centers in Japan. We investigated the histological features and their association with clinical presentation based on cardiomyocyte injury.

View Article and Find Full Text PDF

Aims: Congestive heart failure (HF) is a common complication in patients with acute myocardial infarction (AMI). The estimated plasma volume status [ePVS = (100 - haematocrit)/haemoglobin] is used as the blood plasma volume index to determine the presence of congestion in patients with HF. However, the clinical impact of ePVS at discharge in patients with AMI remains unclear.

View Article and Find Full Text PDF

Background: Cardioprotective drugs have not been previously shown to improve the prognosis in patients with fulminant myocarditis presentation (FMP). We aimed to investigate whether cardioprotective drugs, including angiotensin-converting enzyme inhibitor (ACEI)/angiotensin II receptor blocker (ARB) and β-blocker, administered during hospitalization improved the prognosis in patients with FMP.

Methods And Results: This multicenter cohort study conducted in Japan included 755 patients with clinically diagnosed FMP.

View Article and Find Full Text PDF
Article Synopsis
  • This study investigates myocardial dysfunction in patients with fulminant myocarditis using data from a nationwide registry in Japan, focusing on changes in cardiac function over time.
  • It included 214 patients, analyzing left ventricular ejection fraction (LVEF) at hospital admission, discharge, and one year post-discharge, noting significant improvements in LVEF.
  • Results indicate that patients with reduced LVEF (<50%) at discharge faced a much higher risk of death or heart transplantation compared to those with preserved LVEF (≥50%), highlighting the importance of cardiac function for prognosis.
View Article and Find Full Text PDF

This study aimed to evaluate the prognostic impact and predictors of persistent renal dysfunction in acute kidney injury (AKI) after an emergency percutaneous coronary intervention (PCI) for acute myocardial infarction (AMI). A total of 877 patients who underwent emergency PCI for AMI were examined. AKI was defined as serum creatinine (SCr) ≥ 0.

View Article and Find Full Text PDF
Article Synopsis
  • The study examines differences in clinical outcomes between patients with fulminant lymphocytic myocarditis (FLM) who also have multisystemic inflammation (MSI) versus those without MSI.
  • 39% of the 273 FLM patients were diagnosed with MSI, highlighting that the MSI group tended to be younger and had a higher percentage of female patients, along with a better prognosis as shown by lower mortality rates.
  • The findings indicate that MSI might play a significant role in improving the prognosis of FLM, particularly in younger patients under 50 years old.
View Article and Find Full Text PDF
Article Synopsis
  • Cardiac sarcoidosis (CS) causes scarring in heart muscles due to autoimmune responses, leading to serious heart issues and poor patient outcomes.
  • The study identified certain HLA heterodimer-haplotypes linked to low left ventricular ejection fraction in patients with CS, highlighting specific high-affinity antigenic epitopes that may trigger autoimmune reactions.
  • Researchers found similarities between these epitopes and sequences from bacteria like Cutibacterium acnes and Mycobacterium tuberculosis, suggesting that autoimmune mechanisms might be triggered by molecular mimicry.
View Article and Find Full Text PDF
Article Synopsis
  • Researchers investigated how DNA damage in heart tissue relates to treatment response and prognosis in heart failure patients.
  • The study analyzed biopsy samples from 175 patients, measuring specific DNA damage markers to see how they correlated with the ability to improve heart function one year after treatment.
  • Results showed that higher levels of DNA damage markers were linked to poorer treatment outcomes and a greater risk of serious heart-related events, suggesting that assessing DNA damage can help predict patient prognosis.
View Article and Find Full Text PDF

Background: Several guidelines recommend the measurement of N-terminal pro-B-type natriuretic peptide (NT-proBNP) to diagnose heart failure (HF); however, no screening criteria for measuring NT-proBNP in asymptomatic patients exist. We develop/validate a clinical prediction model for elevated NT-proBNP to support clinical outpatient decision-making.

Methods: In this multicenter cohort study, we used a derivation cohort (24 facilities) from 2017 to 2021 and a validation cohort at one facility from 2020 to 2021.

View Article and Find Full Text PDF

Clinical scenario 1 (CS1) is acute heart failure (HF) characterized by transient systolic blood pressure (SBP) elevation and pulmonary congestion. Although it is managed by vasodilators, the molecular mechanism remains unclear. The sympathetic nervous system plays a key role in HF, and desensitization of cardiac β-adrenergic receptor (AR) signaling due to G protein-coupled receptor kinase 2 (GRK2) upregulation is known.

View Article and Find Full Text PDF

Aims: Heart failure (HF) with preserved ejection fraction (HFpEF) is a complex syndrome with a poor prognosis. Phenotyping is required to identify subtype-dependent treatment strategies. Phenotypes of Japanese HFpEF patients are not fully elucidated, whose obesity is much less than Western patients.

View Article and Find Full Text PDF

Background The fractional excretion of urea nitrogen (FEUN) has been used as a renal blood flow index related to cardiac output, and the estimated plasma volume status (ePVS) as a body fluid volume index. However, the usefulness of their combination in acute decompensated heart failure (HF) management is unclear. We investigated the effect of 4 hemodynamic categories according to the high and low FEUN and ePVS values at discharge on the long-term prognosis of patients with acute decompensated HF.

View Article and Find Full Text PDF

Diagnosis of calcified nodules (CNs) is critical in the proper management of coronary artery disease, but CNs can be detected only using intracoronary imaging modalities. This study aimed to investigate the ability of coronary computed tomography angiography (CCTA) in predicting CNs detected using optical coherence tomography (OCT). From 138 patients who underwent OCT-guided percutaneous coronary intervention (PCI) after CCTA evaluation, 141 PCI target vessels were retrospectively enrolled and classified into CN (12 vessels/11 patients; CNs in the PCI culprit lesion) and non-CN (129 vessels/127 patients; without CNs) groups based on the OCT analysis.

View Article and Find Full Text PDF

Placental growth factor (PlGF) and its receptor, fms-like tyrosine kinase-1 (Flt-1), are important regulators involved in angiogenesis, atherogenesis, and inflammation. This review article focuses on the function of PlGF/Flt-1 signaling and its regulation by soluble Flt-1 (sFlt-1) in chronic kidney disease (CKD). Elevation of circulating sFlt-1 and downregulation of sFlt-1 in the vascular endothelium by uremic toxins and oxidative stress both exacerbate heart failure and atherosclerosis.

View Article and Find Full Text PDF

Background: Fulminant myocarditis presentation (FMP) is a rare and severe presentation of myocarditis. The natural history of FMP and its clinical features associated with poor outcomes are incompletely understood because there is a lack of generalizable evidence.

Methods: This multicenter retrospective cohort study included patients hospitalized with histologically proven myocarditis who underwent catecholamine or mechanical support from 235 cardiovascular training hospitals across Japan between April 2012 and March 2017.

View Article and Find Full Text PDF

Aims: Cancer therapy-related cardiac dysfunction (CTRCD) is commonly reported, but its histopathology, mechanisms, and risk factors are not known. We aimed to clarify the histopathology and mechanisms of CTRCD to identify risk factors.

Methods And Results: We performed myocardial histopathological studies on 13 endomyocardial biopsies from CTRCD patients, 35 autopsied cancer cases with or without cardiac dysfunction, and controls without cancer (10 biopsies and 9 autopsies).

View Article and Find Full Text PDF

Background: Transthyretin (TTR) amyloid cardiomyopathy (ATTR-CM) is increasingly being recognized as a cause of left ventricular (LV) hypertrophy (LVH) and progressive heart failure in elderly patients. However, little is known about the cardiac morphology of ATTR-CM and the association between the degree of TTR amyloid deposition and cardiac dysfunction in these patients.

Methods: We studied 28 consecutive patients with ATTR-CM and analyzed the relationship between echocardiographic parameters and pathological features using endomyocardial biopsy samples.

View Article and Find Full Text PDF

Background: Although B-type natriuretic peptide (BNP) and N-terminal (NT)-proBNP are commonly used markers of heart failure, a simple conversion formula between these peptides has not yet been developed for clinical use.

Methods and results: A total of 9,394 samples were obtained from Nara Medical University, Jichi Medical University, and Osaka University. We randomly selected 70% for a derivation set to investigate a conversion formula from BNP to NT-proBNP using estimated glomerular filtration rate (eGFR) and body mass index (BMI); the remaining 30% was used as the internal validation set and we used a cohort study from Nara Medical University as an external validation set.

View Article and Find Full Text PDF

Dilated cardiomyopathy (DCM) is caused by various gene variants and characterized by systolic dysfunction. Lamin variants have been reported to have a poor prognosis. Medical and device therapies are not sufficient to improve the prognosis of DCM with the lamin variants.

View Article and Find Full Text PDF